AM. Massing, WL. Epstein, Natural History of Warts. A Two-Year Study Arch Dermatol. 1963;87(3):

Transcription

1 Recommended Reading: Warts and their treatment AM. Massing, WL. Epstein, Natural History of Warts. A Two-Year Study Arch Dermatol. 1963;87(3): Christina Boull and David Groth. Update: Treatment of Cutaneous Viral Warts in Children. Pediatric Dermatology Vol. 28 No , 2011 Kwok CS, Gibbs S, Bennett C, Holland R, Abbott R. Topical treatments for cutaneous warts (Review) The Cochrane Library 2012, Issue 10 C.S. Kwok, R. Holland and S. Gibbs Efficacy of topical treatments for cutaneous warts: a meta-analysis and pooled analysis of randomized controlled trials. British Association of Dermatologists , pp Federica Dall'Oglio, Valentina D'Amico, Maria R. Nasca and Giuseppe Micali. Treatment of Cutaneous Warts. An Evidence-Based Review. Am J Clin Dermatol 2012: 13 (2): Sri, JC, Dubina MI, Kao GF, Rady PL, Tyring SK, Gaspari AA. Generalized Verrucosis: A Review of the Associated Diseases, Evaluation, and Treatments. J Am Acad Dermatol 2012; 66: Benjamin S. Daniel, BCom, Dedee F. Murrell, Complete Resolution of Chronic Multiple Verruca Vulgaris Treated With Quadrivalent Human Papillomavirus Vaccine. JAMA DERMATOL/VOL 149 (NO. 3), 370 Nai-Ming L, Yuk-Ming William T. Warts (non-genital). Clin Evid (Online) Loo SK, Tang WY. Warts (non-genital). Clin Evid (Online) Venugopal SS, Murrell DF. Recalcitrant cutaneous warts treated with recombinant quadrivalent human papillomavirus vaccine (types 6, 11, 16, and 18) in a developmentally delayed, 31-year-old white man. Arch Dermatol. 2010; 146(5):

2 Hildesheim A, Herrero R, Wacholder S, et al; Costa Rican HPV Vaccine Trial Group. Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA. 2007;298(7): Buckley DA, Vivier AWPD. The therapeutic use of topical contact sensitizers in benign dermatoses. British Journal of Dermatology 2001; 145: Gordon PM, Aldridge RD, McVittie E, Hunter JAA. Topical diphencyprone for alopecia areata: evaluation of 48 cases after 30 months follow-up. British Journal of Dermatology 1996; 134: Holzer AM, Kaplan LL, Levis WR. Haptens as drugs: Contact allergens are powerful immunomodulators. Journal of Drugs in Dermatology 2006; 5(15): Micali G, Dall Oglio E, Tedeschi A, et al. Treatment of cutaneous warts with squaric acid dibutylester: a decade of experience. Archives of Dermatology 2000; 136: Micali G, Nasca MR, Tedeschi A, Dall Oglio F, Pulvirenti N. Use of squaric acid dibutylester for cutaneous warts in children. Pediatric Dermatology 2000; 17: Orecchia G, Douville H. A three-year treatment of alopecia areata with squaric acid dibutylester. Annali Italiani di Dermatologia Clinica e Sperimentale 1988; 42: Semalty M, Semalty A, Badola A, et al. Semecarpus anacardium Linn.: A review. Pharmacognosy Reviews 2010; 4(7): Van der Steen PHM, Boezeman JBM, Happle R. Topical immunotherapy for alopecia areta: re-evaluation of 139 cases after an additional follow-up period of 19 months. Dermatology 1992; 184: Breitburd F, Ramoz N, Salmon J, et al. HLA control in the progression of human papillomavirus infections. Semin Cancer Biol. 1996;7(6):

3 Lutzner MA, Blanchet-Bardon C, Orth G. Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses. J Invest Dermatol. 1984;83(1 Suppl):18s-25s. Gewirtzman A, Bartlett B, Tyring S. Epidermodysplasia verruciformis and human papilloma virus. Curr Opin Infect Dis. 2008;21(2): Arbiser JL. Genetic immunodeficiencies: cutaneous manifestations and recent progress. J Am Acad Dermatol. 1995;33(1): Lipke MM. An armamentarium of wart treatments. Clin Med.Res.2006;4(4): Dehghani F, Merat A, Panjehshahin MR, et al. Healing effect of garlic extract on warts and corns. Int J Dermatol. 2005;44(7): Litt JZ. Don't excise--exorcise. Treatment for subungual and periungual warts. Cutis. 1978;22(6): Focht DR, 3rd, Spicer C, Fairchok MP. The efficacy of duct tape vs cryotherapy in the treatment of verruca vulgaris (the common wart). Arch Pediatr Adolesc Med. 2002;156(10): Rivera A, Tyring SK. Therapy of cutaneous human Papillomavirus infections. Dermatol Ther. 2004;17(6): Lauchli S, Kempf W, Dragieva G, et al. CO2 laser treatment of warts in immunosuppressed patients. Dermatology. 2003;206(2): Horn TD, Johnson SM, Helm RM, et al. Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial. Arch Dermatol. 2005;141(5):

4 Rogers CJ, Gibney MD, Siegfried EC, et al. Cimetidine therapy for recalcitrant warts in adults: is it any better than placebo? J Am Acad Dermatol. 1999;41(1): Mitsuishi T, Iida K, Kawana S. Cimetidine treatment for viral warts enhances IL-2 and IFN-gamma expression but not IL-18 expression in lesional skin. Eur J Dermatol. 2003;13(5): Snoeck R, Bossens M, Parent D, et al. Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection. Clin Infect Dis. 2001;33(5): Allergic contact dermatitis and its treatment Belsito, DV: Contact Dermatitis, allergic and irritant (Chapter 12, pp ) in Clinical Immunodermatology Textbook. Eds. S. Tyring and A.A. Gaspari. Springer, NY, NY 2008 Mathias C. The cost of occupational disease. Arch Dermatol 1985;121: Scheynius A, Fischer T, Forsum U, et al. Phenotypic characterization in situ of inflammatory cells in allergic and irritant contact dermatitis in vivo. Clin Exp Immunol 1984;55: Scheynius A, Fischer T. Phenotypic differences between allergic and irritant patch test reactions in man. Contact Dermatitis 1986;14: Sulzberger MB. The patch test: who should and should not use it and why. Contact Dermatitis 1975;1: Marks JG Jr, Moss JH, Parno JR, et al. Methylchloroisothiazolinone/ methylisothiazolinone (Kathon CG) Biocide-United States multicenter study of human skin sensitization. Am J Contact Dermatitis 1990;1: Epstein WL. The use test for contact hypersensitivity.arch Dermatol Res 1982;272:

5 Mitchell JC. Multiple concomitant positive patch test reactions. Contact Dermatitis 1975;3: Przybilla B, Burg G, Thieme C. Evaluation of the immune status in vivo by the 2,4 dinitro-1 chlorobenzene contact allergy time (DNCB-CAT).Dermatologica 1983;167:1 5. Belsito DV, Storrs FJ, Taylor JS, et al. Reproducibility of patch tests: a U.S. multicenter study. Am J. Contact Dermatitis 1992;3: Rietschel RL, Fowler JF Jr. Fisher s Contact Dermatitis,5th ed. Baltimore: Williams & Wilkins, Guin JD. Practical Contact Dermatitis. New York:McGraw-Hill, Psoriasis and its treatment Treatment considerations Gaspari AA and Tyring S. New and emerging biologic therapies for moderate-tosevere plaque psoriasis: mechanistic rationales and recent clinical data for IL-17 and IL-23 inhibitors. Dermatologic Therapy 28: ; 2015 Menter A, et al. J Am Acad Dermatol. 2008;58: Heydendael VM, et al. N Engl J Med. 2003;349: Saurat JH, et al. Br J Dermatol. 2008;158: Papp K, et al. J Am Acad Dermatol. 2015;73: Leonardi CL, et al. N Engl J Med. 2003;349: Menter A, et al. J Am Acad Dermatol. 2010;63: Reich K, et al. Lancet. 2005;366: Leonardi CL, et al. Lancet. 2008;371: Langley RG, et al. N Engl J Med. 2014;371:

6 Griffiths CE, et al. Lancet. 2015;386: Lebwohl M, et al. N Engl J Med. 2015;373: Psoriasis co-morbidities Prey S, et al. J Eur Acad Dermatol Venereol. 2010;24(suppl 2): Busse K, et al. Psoriasis Forum. 2010;16: Armstrong EJ, et al. J Am Heart Assoc. 2013;2:e Gelfand JM, et al. Arch Dermatol. 2007;143: Abuabara K, et al. Br J Dermatol. 2010;163: